We put biotechnologies at the service of animal health by designing and developing ethical and sustainable solutions for farmed and companion animals.
Company
Introduction
Founded in 2022 by a veterinarian with extensive expertise in Research & Development, BioAZ is a biotechnology company redefining animal health through a new generation of immunotherapies.
Built on scientific excellence and a deep understanding of field realities, BioAZ develops high-value solutions that enhance animal health and welfare while supporting the transition toward more sustainable, responsible, and ethical livestock farming practices.
Driven by the needs of livestock producers, pet owners, and veterinarians, BioAZ transforms unmet market needs into tangible innovations. Its ambition is to develop breakthrough therapies that address today’s animal health challenges while anticipating those of tomorrow, contributing to a more effective, sustainable, and resilient approach to animal health.
The founder
Romain Delcombel has 15 years of experience in innovation, research and development of medicines for human and veterinary use.
After following entrepreneurship training at INSEAD in 2021, he founded the company BioAZ in 2022 with the aim of developing immunotherapies dedicated to animal health and well-being, with the immunocastration of pigs as his first project. in response to the problem of boar taint.
Our vision, our mission, our values
Our vision
We put biotechnologies at the service of animal health and develop ethical solutions for farmed and companion animals.Our mission
BioAZ relies on innovative biotechnologies to bring to market immunotherapies that are easy to use, profitable/economical, safe (for the user and the animal), ethical and more respectful of the environment.
Our values
BioAZ strives to:
-Promote animal welfare and sustainable development,
-Participate in the ambitions of the agroecological transition and the “One Health” concept,
-Promote the employment of researchers in France,
-Participate in regional and national industrial development.
Scientific projects
Investors and Partners
News and Media
